![]() |
Volumn 99, Issue 21, 2007, Pages 1613-1622
|
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
ESTRAMUSTINE;
ETOPOSIDE;
KETOCONAZOLE;
PACLITAXEL;
PROSTATE SPECIFIC ANTIGEN;
VINBLASTINE;
VINCRISTINE;
AGED;
ALGORITHM;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
HUMAN;
IMMUNOLOGY;
MALE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PROSPECTIVE STUDY;
PROSTATE TUMOR;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL MODEL;
SURVIVAL;
TREATMENT OUTCOME;
AGED;
ALGORITHMS;
ANDROGENS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CONFIDENCE INTERVALS;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
ESTRAMUSTINE;
ETOPOSIDE;
HUMANS;
KETOCONAZOLE;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PROSPECTIVE STUDIES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RESEARCH DESIGN;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VINBLASTINE;
VINCRISTINE;
|
EID: 36048985798
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djm189 Document Type: Article |
Times cited : (56)
|
References (0)
|